Skip to content

Author

Hua-Fang Wang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Risk Factors for Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation Using Rabbit Anti-thymocyte Globulin or Porcine Anti-human T Lymphocyte Immunoglobulin in the Letermovir Era.

BACKGROUND Letermovir (LTV) prophylaxis has reduced clinically significant cytomegalovirus (CMV) infection (csCMVi) after allogeneic hematopoietic cell transplantation (allo-HCT). In vivo T-cell depletion is widely used for graft-versus-host disease (GVHD) prevention but is associated with increased risk of CMV infecti...

Xin-Yi Jiang, Yi-Fan Yao, Xiao-Yan Zhao et al. · 0 citations
Open access Aug 2026

T-cell engager bispecific antibodies enable T cells to eliminate Multiple Myeloma by targeting tumor CD38 in combination with PD-L1

In vitro data revealed that a bispecific antibody simultaneously engaging PD-L1 and CD38 exhibited markedly enhanced antitumor efficacy—even under conditions of reduced CD38 surface expression on MM cells.

Chaofan Wang, Wanting Wang, Mo-Ran Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.